Michael Krebs
Chief Executive Officer at Heartbeat.bio AG
Profile
Mr. Michael Krebs is a Head of Customer Service & Member of the Executive Board at Privatbank Von Graffenried AG and a Chief Executive Officer at HeartBeat.bio AG.
Michael Krebs active positions
Companies | Position | Start |
---|---|---|
Privatbank Von Graffenried AG
Privatbank Von Graffenried AG Investment ManagersFinance Part of Von Graffenried Holding AG, Privatbank Von Graffenried AG is a Swiss company that provides investment advice. The company is based in Bern, Switzerland. The company was founded in 1979. Marcel Eggimann has been the CEO of the company since 1996. | Portfolio Manager-Equities | 2007-12-31 |
Heartbeat.bio AG
Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Privatbank Von Graffenried AG
Privatbank Von Graffenried AG Investment ManagersFinance Part of Von Graffenried Holding AG, Privatbank Von Graffenried AG is a Swiss company that provides investment advice. The company is based in Bern, Switzerland. The company was founded in 1979. Marcel Eggimann has been the CEO of the company since 1996. | Finance |
Heartbeat.bio AG
Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Michael Krebs